P3781
Abatacept in the Treatment of UveitisBelatacept in Kidney Transplantation of Moderately Sensitized PatientsEffects of Abatacept on Myocarditis in Rheumatoid ArthritisA Phase III Study of Abatacept in Japanese Subjects With Rheumatoid ArthritisA Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney TransplantationA Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateSafety Study of Abatacept in SwedenBelatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant StudyEfficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis VulgarisKorean College of Rheumatology Biologics RegistryIntravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes MellitusPrevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes MellitusRheumatoid Arthritis Memory B Cells and Abatacept (RAMBA)A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That OccurA Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different ProcessesComparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic MalignancyImpact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in AustraliaStudy of Belatacept in Subjects Who Are Undergoing a Renal TransplantAbatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate RespondersSafety Study of Abatacept to Treat Refractory SarcoidosisBelatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) ScoresActive Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose ReductionPatterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant StudyPharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers SquibbBenefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) PatientsEfficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN45A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating AbataceptAn Observational Registry of Abatacept in Patients With Juvenile Idiopathic ArthritisAbatacept Treatment in Polymyositis and DermatomyositisUltrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid ArthritisAbatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/UniversalisSWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study)The Immunogenicity and Safety of Zostavax® in Rheumatoid Arthritis Patients Using AbataceptAbatacept in earLy Onset Polymyalgia Rheumatica: Study ALORSEffects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis PatientsSafety and Effectiveness of Abatacept in Psoriatic Arthritis ParticipantsBelatacept Pilot Study in Lung Transplantation Immunosuppression in Lung TransplantationAbdominal Wall Transplant
P4844
Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in miceIntravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label studyCurrent advances in the treatment of giant cell arteritis: the role of biologics
P921
Q61864922-6ACFE82A-4513-4DF2-A6C3-5CD34419BE4BQ61894370-7C4B1CB3-A3D7-4F98-A999-A6789CAF5205Q61902740-0C6EC4BB-C5C7-4739-A09F-2CD5CDB88FF6Q61918612-891108E2-2001-4461-8A3E-11A9C7947832Q61920664-2D4F7C80-57DB-4578-A9FD-D2143B372B25Q61921998-2A6F45A8-E4E5-4D1C-BBCF-8923DB9518C5Q61936735-34D4B81B-512D-494B-ADFF-1CE7F0C0E23EQ61955585-BA5FEFB4-CE64-473E-B5AE-D4B88A4E02E1Q61969335-5ED25EEE-1E68-4EED-A101-24FA6B171E94Q61975787-B0030A1E-4C94-40DD-AF86-F123EC2C855DQ61979995-B7979B33-0B35-4AE7-8C2E-72F7A1E29B9BQ61980315-01743A67-B111-4F25-B7E4-206C5258235DQ62025209-3FC2A79F-41E2-40D8-8720-2309A24A51CDQ62031461-495B4E1F-60E1-49E8-BDF6-815D72A020F4Q62035376-527095C3-F716-4AB6-814C-E985EBE06170Q62041317-4ABFBA6A-1C45-40E7-A605-D24B25D74181Q62055013-B20447B1-A9C8-4653-A06E-4174AEBE8F96Q62062121-289D5EC3-C033-4C59-B90A-1AED26279FBFQ62104829-F7DEE3C9-8EE3-4FA9-99B3-86ABA17231FAQ63013370-38ABC3EC-1E7B-4925-82B1-2C9E3ACD05B5Q63062869-696AB421-4425-4499-84D3-B15A91284767Q63319117-63853252-368A-4BD7-9D19-881B55F2762BQ63320406-CB347572-6647-469D-898D-6260B921DB19Q63320666-2F2C50BF-1B7C-4500-8532-95DDE03FAD0CQ63322711-3B07C08F-F4C2-41D8-9BB6-44AC0F62D755Q63334505-FF0904AC-C4EC-43BC-94E2-076823C1C8DBQ63334712-05578C5D-7635-407F-8143-1B6E28403F9AQ63335053-59EDE33D-DF26-42BF-A48B-4C1C0300E6F8Q63336317-5684BEDD-8570-4AA0-BC7C-1E7C54C03F68Q63338216-7F24904E-73B9-406C-8EE7-CDFD2F582BDEQ63338326-1540851F-D56C-4BF5-8E3C-06F3358DFB6DQ63338566-F62A49BE-19BF-41DB-B3B2-B4AC0800B88CQ63339277-2CB38686-A686-4DB6-9C57-9A1ACB967597Q63392915-904B2C64-0FBF-409A-925D-58263D1D37C6Q63394217-C0F6304B-93AD-488D-AEEC-642BD0679917Q63394724-8C285340-B55E-4238-9E30-039BEDA52D5DQ63401040-DE6CC185-1A34-445C-A03A-047C312F9F29Q63403998-B4E3E785-2B88-4087-8C39-F32540130DEFQ63405618-2F8CC9EE-A192-4D8E-86E8-F70D1F1B590EQ63571827-BFD695E2-F52B-43DD-900F-FF95386655ED
P4844
description
Actemra
@de
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Abatacept
@de
Abatacept
@en
Abatacept
@es
Abatacept
@nl
Abatacept
@pt
Abatacept
@sh
Abatacept
@sr
Abatacept
@vi
Orenzio
@pdc
abatacept
@fr
type
label
Abatacept
@de
Abatacept
@en
Abatacept
@es
Abatacept
@nl
Abatacept
@pt
Abatacept
@sh
Abatacept
@sr
Abatacept
@vi
Orenzio
@pdc
abatacept
@fr
altLabel
BMS-188667
@en
CTLA4-Ig
@en
CTLA4-IgG4m
@en
CTLA4Ig
@en
CTLA4IgG4m
@en
RG-1046
@en
RG-2077
@en
prefLabel
Abatacept
@de
Abatacept
@en
Abatacept
@es
Abatacept
@nl
Abatacept
@pt
Abatacept
@sh
Abatacept
@sr
Abatacept
@vi
Orenzio
@pdc
abatacept
@fr
P31
P486
P592
P6366
P646
P665
P2115
N0000171747
P2275
Abatacept
@en
P231
332348-12-6
P267
P3345
P3780
P486
D000069594
P592
CHEMBL1201823
P6366
2779605438
P646
/m/02phdqs